Vinge advises Eleda’s shareholders in connection with partnership with Altor

Vinge has advised the shareholders of Eleda Infra Services Group (“Eleda”) on the divestment of a majority stake in Eleda to Altor Fund V.

Vinge advises Eleda in connection with acquisition of One Nordic

Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of One Nordic from Altor Fund III.

Vinge advises Eleda in connection with acquisition of JVAB

Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of Järfälla VA- & Byggentreprenad AB (“JVAB”).

Vinge advises Eleda in connection with divestment of KEWAB

Vinge has advised Eleda Infra Services Group (“Eleda”) on the divestment of KEWAB, Kenneth Wahlström Aktiebolag. The divestment is carried out in connection with Altor Fund V’s acquisition of a majority stake in Eleda and Eleda’s acquisitions of Järfälla VA- & Byggentreprenad AB and ONE Nordic.

Vinge has advised Nascent Invest in connection with an investment in Pro Test Diagnostics

Vinge has advised Nascent Invest in connection with their investment in Pro Test Diagnostics, which has produced a unique test kit for blood doping.

Vinge has advised Equinor ASA in connection with a sale of shares in Lundin Energy

Vinge has advised Equinor ASA in connection with a sale of shares in Lundin Energy AB (publ) through an accelerated bookbuilding process. In total, approximately 14,000,000 shares were placed at a price of SEK 235 per share, corresponding to a total value of approximately SEK 3.3 billion.

Vinge advises when Lendify, a fintech company and one of Sweden’s largest challengers to the banking sector, completes a share issue of SEK 148m

Vinge has advised Lendify AB (publ) (”Lendify”) in connection with raising of capital from new and current shareholders in an investment round in a total amount of approximately SEK 148 million.

Vinge has advised CELLINK AB (publ) in connection with its listing on Nasdaq Stockholm

Vinge has advised CELLINK AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm Main Market, with an estimated market capitalisation of approximately SEK 4.1 billion. The prospectus was published on 15 April 2020 and the trading on Nasdaq Stockholm commenced on 20 April 2020.

Vinge has advised Ventech in connection with their investment in Mindler

Vinge has advised Ventech, a leading Seed & Series A-focused European venture capital firm, in connection with their investment in Mindler, Sweden’s largest digital service for mental health.

Vinge advises Platzer in connection with an acquisition

Vinge advised Platzer when the joint venture company Sörreds Logistikpark was formed together with Bockasjö and Sörreds Logistikpark in the acquisition of AB Platzer Sörred 8:12 and the property Göteborg Sörred 8:12 from Platzer.

Vinge advises the founders in connection with the divestment of the Draftit Group to Visma Sverige Holding AB ("Visma")

Vinge advises the founders of Draftit, a leading provider of web-based compliance services and support for inter alia human resources (“HR”) and GDPR, in connection with the divestment of the Draftit Group to Visma Sverige Holding AB ("Visma").

Vinge has advised Main Capital in connection with its acquisition of Alfa Kommun & Landsting AB and Safe Care Svenska AB

Alfa Kommun & Landsting AB and Safe Care Svenska AB develop and provide software solutions to both public and private healthcare providers and the companies employ close to 40 employees and serve more than 400 customers throughout Sweden.

Vinge has advised Mitsubishi Electric in connection with acquisition 

Vinge has advised Mitsubishi Electric’s European subsidiary Mitsubishi Electrics B.V. in connection with its acquisition of AQS Produkter AB, a distributor of comfort, process and IT cooling and heat pumps in Sweden.

Vinge advises Camfil in connection with the acquisition of Resema

Vinge has advised Camfil Svenska AB in connection with the acquisition of all shares in Resema AB and Resema AS.

Vinge advises Isofol in conjunction with capital procurement

Vinge has advised Isofol Medical AB (publ), First North Growth Market Premier, in connection with its rights issue in the total amount of MSEK 150 and, conditional upon oversubscription in respect of the rights issue, a directed new issue of shares of a total amount of MSEK 30.